INSERM, Centre d'Investigations Cliniques Plurithématique 1433, Université de Lorraine, CHRU de Nancy and F-CRIN INI-CRCT, Nancy, France.
Cardiovascular Research and Development Unit, Department of Physiology and Cardiothoracic Surgery, University of Porto, Porto, Portugal.
Heart. 2018 Apr;104(7):606-613. doi: 10.1136/heartjnl-2017-311750. Epub 2017 Aug 10.
Coronary angiography is regularly performed in patients with worsening signs and/or symptoms of heart failure (HF). However, little is known on the determinants, findings and associated clinical outcomes of coronary angiography performed in patients with worsening HF.
The BIOSTAT-CHF (a systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure) programme enrolled 2516 patients with worsening symptoms and/or signs of HF, either hospitalised or in the outpatient setting. All patients were included in the present analysis.
Of the 2516 patients included, 315 (12.5%) underwent coronary angiography within the 30 days after the onset of worsening symptoms and/or signs of HF. Subjects who underwent angiography were more often observed as inpatients, had more often an overt acute coronary syndrome, had higher troponin I levels, were younger and had better renal function (all p≤0.01). Patients who underwent coronary angiography had a lower risk of the primary outcome of death and/or HF hospitalisation (adjusted HR=0.71, 95% CI 0.57 to 0.89, p=0.003) and death (adjusted HR=0.59, 95% CI 0.43 to 0.80, p=0.001). Among the patients who underwent coronary angiography, those with a coronary stenosis (39%) had a worse prognosis than those without stenosis (adjusted HR for the primary outcome=1.71, 95% CI 1.10 to 2.64, p=0.016).
Coronary angiography was performed in <13% of patients with symptoms and/or signs of worsening HF. These patients were remarkably different from those who did not undergo coronary angiography and had a lower risk of subsequent events. The presence of coronary stenosis on coronary angiography was associated with a worse prognosis.
在出现心力衰竭(HF)症状和/或体征恶化的患者中,常进行冠状动脉造影检查。然而,对于在 HF 恶化患者中进行冠状动脉造影检查的决定因素、检查结果和相关临床结局知之甚少。
BIOSTAT-CHF(一项针对慢性心力衰竭个体化治疗的系统生物学研究)计划纳入了 2516 例出现 HF 症状和/或体征恶化的住院或门诊患者。本分析纳入了所有患者。
在纳入的 2516 例患者中,有 315 例(12.5%)在 HF 症状和/或体征恶化后 30 天内进行了冠状动脉造影检查。接受造影检查的患者更多地被观察为住院患者,更常出现明显的急性冠状动脉综合征,肌钙蛋白 I 水平更高,年龄更小,肾功能更好(均 P≤0.01)。接受冠状动脉造影检查的患者发生主要结局(死亡和/或 HF 住院)的风险较低(校正 HR=0.71,95%CI 0.57 至 0.89,P=0.003)和死亡(校正 HR=0.59,95%CI 0.43 至 0.80,P=0.001)的风险也较低。在接受冠状动脉造影检查的患者中,有冠状动脉狭窄(39%)的患者预后较无狭窄者差(主要结局校正 HR=1.71,95%CI 1.10 至 2.64,P=0.016)。
在出现 HF 症状和/或体征恶化的患者中,仅有不到 13%的患者进行了冠状动脉造影检查。这些患者与未接受冠状动脉造影检查的患者明显不同,且随后发生事件的风险较低。冠状动脉造影检查显示冠状动脉狭窄与预后较差相关。